NeoGenomics

Corey Perrine/Staff Felix De La Cruz, a cytogeneic technician, thumbs through patient information Nov. 15, 2012 at the NeoGenomics facility in Fort Myers, Fla. The company may soon be trading on Nasdaq because its stock price has risen enough and held up long enough to be listed. The company, which specializes in genetic-based cancer testing, is one of the fastest growing lab companies in the country.

Corey Perrine/Staff Vials of white blood samples sit Nov. 15, 2012 at the NeoGenomics facility in Fort Myers, Fla. The company may soon be trading on Nasdaq because its stock price has risen enough and held up long enough to be listed. The company, which specializes in genetic-based cancer testing, is one of the fastest growing lab companies in the country.

Corey Perrine/Staff Arlene Ignacia, a medical technician, prepares cell samples to separate white and red blood cells via a centrifuge machine Nov. 15, 2012 at the NeoGenomics facility in Fort Myers, Fla. The company may soon be trading on Nasdaq because its stock price has risen enough and held up long enough to be listed. The company, which specializes in genetic-based cancer testing, is one of the fastest growing lab companies in the country.

Corey Perrine/Staff Steven C. Jones, Executive Vice President, Finance, left, and Douglas M. VanOort, Chairman and CEO are seen in portrait Nov. 15, 2012 at the NeoGenomics facility in Fort Myers, Fla. The company may soon be trading on Nasdaq because its stock price has risen enough and held up long enough to be listed. The company, which specializes in genetic-based cancer testing, is one of the fastest growing lab companies in the country.

Corey Perrine/Staff Pat Turner, a histotechnologist, works at a computer next to a machine that stain cell samples Nov. 15, 2012 at NeoGenomics facility in Fort Myers, Fla. The company may soon be trading on Nasdaq because its stock price has risen enough and held up long enough to be listed. The company, which specializes in genetic-based cancer testing, is one of the fastest growing lab companies in the country.

Corey Perrine/Staff Brianna Hoffman, a medical technician, uses a dropper on a vial of cells Nov. 15, 2012 at NeoGenomics facility in Fort Myers, Fla. The company may soon be trading on Nasdaq because its stock price has risen enough and held up long enough to be listed. The company, which specializes in genetic-based cancer testing, is one of the fastest growing lab companies in the country.

Corey Perrine/Staff Nikki Southall, a cytogenetic technician, agitates a vial of cells Nov. 15, 2012 at the NeoGenomics facility in Fort Myers, Fla. The company may soon be trading on Nasdaq because its stock price has risen enough and held up long enough to be listed. The company, which specializes in genetic-based cancer testing, is one of the fastest growing lab companies in the country.

Corey Perrine/Staff Chairman and CEO, Douglas M. VanOort Nov. 15, 2012 at the NeoGenomics facility in Fort Myers, Fla. The company may soon be trading on Nasdaq because its stock price has risen enough and held up long enough to be listed. The company, which specializes in genetic-based cancer testing, is one of the fastest growing lab companies in the country.